Advisory Services Network’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $868K | Buy |
9,591
+735
| +8% | +$61.6K | 0.01% | 1093 |
|
|
2026
Q1 | $709K | Sell |
8,856
-3,803
| -30% | -$314K | 0.01% | 1100 |
|
|
2025
Q4 | $1.08M | Buy |
12,659
+500
| +4% | +$41K | 0.02% | 856 |
|
|
2025
Q3 | $946K | Sell |
12,159
-196
| -2% | -$15.3K | 0.01% | 893 |
|
|
2025
Q2 | $980K | Sell |
12,355
-12,208
| -50% | -$910K | 0.02% | 831 |
|
|
2025
Q1 | $1.78M | Sell |
24,563
-2,866
| -10% | -$205K | 0.03% | 535 |
|
|
2024
Q4 | $2.03M | Buy |
27,429
+11,263
| +70% | +$788K | 0.04% | 489 |
|
|
2024
Q3 | $1.49M | Hold |
16,166
| – | – | 0.03% | 566 |
|
|
2024
Q2 | $1.49M | Sell |
16,166
-1,258
| -7% | -$111K | 0.03% | 566 |
|
|
2024
Q1 | $1.66M | Sell |
17,424
-5,248
| -23% | -$441K | 0.04% | 512 |
|
|
2023
Q4 | $1.73M | Sell |
22,672
-20,022
| -47% | -$1.39M | 0.04% | 469 |
|
|
2023
Q3 | $2.96M | Buy |
42,694
+10,907
| +34% | +$876K | 0.08% | 283 |
|
|
2023
Q2 | $3M | Sell |
31,787
-1,216
| -4% | -$106K | 0.08% | 296 |
|
|
2023
Q1 | $2.73M | Sell |
33,003
-11,233
| -25% | -$883K | 0.08% | 304 |
|
|
2022
Q4 | $3.3M | Sell |
44,236
-15,132
| -25% | -$1.17M | 0.1% | 240 |
|
|
2022
Q3 | $4.91M | Sell |
59,368
-1,838
| -3% | -$177K | 0.17% | 135 |
|
|
2022
Q2 | $5.82M | Buy |
61,206
+2,294
| +4% | +$237K | 0.2% | 118 |
|
|
2022
Q1 | $6.93M | Buy |
58,912
+10,033
| +21% | +$1.13M | 0.2% | 103 |
|
|
2021
Q4 | $6.33M | Sell |
48,879
-2,339
| -5% | -$273K | 0.18% | 118 |
|
|
2021
Q3 | $5.8M | Buy |
51,218
+6,787
| +15% | +$775K | 0.18% | 129 |
|
|
2021
Q2 | $4.6M | Buy |
44,431
+3,098
| +7% | +$292K | 0.15% | 178 |
|
|
2021
Q1 | $3.46M | Buy |
41,333
+1,940
| +5% | +$164K | 0.13% | 206 |
|
|
2020
Q4 | $3.59M | Sell |
39,393
-2,440
| -6% | -$202K | 0.14% | 178 |
|
|
2020
Q3 | $3.34M | Sell |
41,833
-834
| -2% | -$65.1K | 0.16% | 161 |
|
|
2020
Q2 | $2.95M | Sell |
42,667
-410
| -1% | -$29.1K | 0.16% | 162 |
|
|
2020
Q1 | $2.71M | Sell |
43,077
-1,548
| -3% | -$112K | 0.18% | 145 |
|
|
2019
Q4 | $3.47M | Sell |
44,625
-171
| -0.4% | -$13.4K | 0.18% | 140 |
|
|
2019
Q3 | $2.76M | Hold |
44,796
| – | – | 0.17% | 148 |
|
|
2019
Q2 | $2.76M | Buy |
44,796
+177
| +0.4% | +$10.7K | 0.17% | 148 |
|
|
2019
Q1 | $2.85M | Buy |
44,619
+561
| +1% | +$32K | 0.2% | 131 |
|
|
2018
Q4 | $2.25M | Buy |
44,058
+2,448
| +6% | +$124K | 0.2% | 128 |
|
|
2018
Q3 | $2.42M | Buy |
41,610
+507
| +1% | +$24.8K | 0.18% | 145 |
|
|
2018
Q2 | $2.12M | Buy |
41,103
+840
| +2% | +$39.2K | 0.16% | 164 |
|
|
2018
Q1 | $1.87M | Buy |
40,263
+462
| +1% | +$20.1K | 0.15% | 176 |
|
|
2017
Q4 | $1.5M | Buy |
39,801
+561
| +1% | +$20.6K | 0.13% | 211 |
|
|
2017
Q3 | $1.43M | Buy |
39,240
+1,545
| +4% | +$58.9K | 0.16% | 157 |
|
|
2017
Q2 | $1.49M | Buy |
37,695
+336
| +0.9% | +$12.3K | 0.19% | 135 |
|
|
2017
Q1 | $1.17M | Buy |
+37,359
| New | +$1.17M | 0.17% | 148 |
|
|
2016
Q3 | $832K | Buy |
+20,703
| New | +$780K | 0.16% | 168 |
|
|
2016
Q2 | – | Sell |
-22,086
| Closed | -$649K | – | 1864 |
|
|
2016
Q1 | $649K | Buy |
22,086
+720
| +3% | +$19.9K | 0.18% | 154 |
|
|
2015
Q4 | $562K | Buy |
21,366
+6,180
| +41% | +$160K | 0.18% | 141 |
|
|
2015
Q3 | $360K | Buy |
+15,186
| New | +$367K | 0.11% | 191 |
|
Other funds holding EW
Advisory Services Network's EW Position: Q2 2026 in Review
Advisory Services Network increased its Edwards Lifesciences (EW) stake by 8.3% in Q2 2026, buying an estimated $61.6K and bringing the position to 9,591 shares worth $868K. The position accounts for 0.01% of the portfolio, ranked #1093.
Advisory Services Network first reported a position in EW in Q3 2015 and has held it in 42 quarters since. The position peaked at $6.93M in Q1 2022. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Advisory Services Network held 9,591 shares of Edwards Lifesciences worth $868K as of Q2 2026.
- Advisory Services Network bought 735 Edwards Lifesciences shares in Q2 2026, an estimated $61.6K.
- Edwards Lifesciences made up 0.01% of Advisory Services Network's portfolio in Q2 2026, its #1093 holding.
- Advisory Services Network first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 42 quarters since.
- Advisory Services Network's Edwards Lifesciences position peaked at $6.93M in Q1 2022.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.